Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

PDE4 inhibitors described by Merck Frosst

Jan. 14, 2005

Antiinfective agents claimed by GlaxoSmithKline

Jan. 13, 2005

Roche scientists prepare and test new agents for cancer

Jan. 13, 2005

GSK team identifies new 5-HT5A receptor ligands for CNS disorders

Jan. 13, 2005

HIV integrase inhibitors in early development at Bristol-Myers Squibb

Jan. 13, 2005

Antibacterial ketolides described by Chiron scientists

Jan. 13, 2005

Researchers at Actelion disclose orexin receptor antagonists

Jan. 13, 2005

New agents for Alzheimer's disease claimed by De Novo

Jan. 13, 2005

Muscarinic M1 receptor antagonists emerge from research at Lilly

Jan. 12, 2005

Scientists at Enanta report novel agents for hepatitis C infections

Jan. 12, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...